Education: Doctor of Pharmacy, Rutgers University (2018)

Residencies: PGY1 Pharmacy Residency, St. Joseph’s Hospital and Medical Center (2019); PGY2 Infectious Diseases Pharmacy Residency, Barnes-Jewish Hospital (2020)

Practice/Research Interests: Gram-negative resistance, antimicrobial stewardship, infections in immunocompromised patients

Select Publications: 

Rogers R, Krause PJ, Norris AM, Ting MH, et al. Broad antimicrobial resistance in a case of relapsing babesiosis successfully treated with tafenoquine. Clin Infect Dis. 2022:doi:10.1093/cid/ciac473.

Ting MH, Spec A, Micek ST, Ritchie DJ, Krekel T. Evaluation of total body weight versus adjusted body weight liposomal amphotericin B dosing in obese patients. Antimicrob Agents Chemother. 2021;65:e0236620.

Ting MH, Radosevich JJ, Weinberg JA, Nailor MD. Narrowing antibiotic spectrum of activity for trauma-associated pneumonia through the use of a disease-specific antibiogram. Trauma Surg Acute Care Open. 2021;6:e000602.

Michelle Ting, PharmD is the antimicrobial stewardship and infectious diseases pharmacist at Rhode Island Hospital, performing antimicrobial stewardship functions and participating in multidisciplinary rounds with the infectious diseases consult team. She serves on the Lifespan Antimicrobial Stewardship Program Committee and the Infection Control Committee. She also serves as a guest lecturer at Johnson and Wales University and Bryant University, in addition to precepting students from local schools of pharmacy.